Preclinical evaluation of dasatinib in melanoma cell lines

被引：0
|
作者：
Eustace, A. J. [1 ]
Crown, J. [2 ]
Clynes, M. [1 ]
O'Donovan, N. [1 ]
机构：
[1] Dublin City Univ, Natl Insititute Cellular Biotechnol, Dublin 9, Ireland
[2] St Vincents Hosp Dublin 4, Dept Oncol, Dublin, Ireland
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 09期
关键词：
D O I：
10.1016/S1359-6349(08)71602-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [1] Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines
    Alex J Eustace
    John Crown
    Martin Clynes
    Norma O'Donovan
    Journal of Translational Medicine, 6
  • [2] Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines
    Eustace, Alex J.
    Crown, John
    Clynes, Martin
    O'Donovan, Norma
    JOURNAL OF TRANSLATIONAL MEDICINE, 2008, 6 (1)
  • [3] The requirements for dasatinib sensitivity in human melanoma cell lines
    Vachtenheim, Jiri
    Reda, Jiri
    Ondrusova, Lubica
    Zakova, Petra
    CANCER RESEARCH, 2014, 74 (19)
  • [4] Effects of Src kinase inhibition by dasatinib in melanoma cell lines
    Eustace, A.
    Crown, J.
    Clynes, M.
    O'Donovan, N.
    ANNALS OF ONCOLOGY, 2008, 19 : 44 - 44
  • [5] Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemia
    Yoshimura, Satoshi
    Panetta, John C.
    Hu, Jianzhong
    Li, Lie
    Gocho, Yoshihiro
    Du, Guoqing
    Umezawa, Akihiro
    Karol, Seth E.
    Pui, Ching-Hon
    Mullighan, Charles G.
    Konopleva, Marina
    Stock, Wendy
    Teachey, David T.
    Jain, Nitin
    Yang, Jun J.
    LEUKEMIA, 2023, 37 (06) : 1194 - 1203
  • [6] Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemia
    Satoshi Yoshimura
    John C. Panetta
    Jianzhong Hu
    Lie Li
    Yoshihiro Gocho
    Guoqing Du
    Akihiro Umezawa
    Seth E. Karol
    Ching-Hon Pui
    Charles G. Mullighan
    Marina Konopleva
    Wendy Stock
    David T. Teachey
    Nitin Jain
    Jun J. Yang
    Leukemia, 2023, 37 : 1194 - 1203
  • [7] Molecular cytogenetic evaluation of ten uveal melanoma cell lines
    White, JS
    Becker, RL
    McLean, IW
    Nath, J
    Director-Myska, AE
    LABORATORY INVESTIGATION, 2003, 83 (01) : 300A - 300A
  • [8] Molecular cytogenetic evaluation of 10 uveal melanoma cell lines
    White, Jason S.
    Becker, Robert L.
    McLean, Ian W.
    Director-Myska, Alison E.
    Nath, Joginder
    CANCER GENETICS AND CYTOGENETICS, 2006, 168 (01) : 11 - 21
  • [9] Molecular cytogenetic evaluation of ten uveal melanoma cell lines
    White, JS
    Becker, RL
    McLean, IW
    Nath, J
    MODERN PATHOLOGY, 2003, 16 (01) : 300A - 300A
  • [10] Preclinical evaluation of combination therapy with dasatinib and sorafenib for the treatment of brain metastases
    Zhou, Qingyu Stephanie
    Guo, Xiaofang
    CANCER RESEARCH, 2017, 77
12345